Sign inJoin waitlistJoin the waitlist

Foluso Ademuyiwa

Medical Oncologist · Alvin J. Siteman Cancer Center

Credentials: · · · · · · ·

History

Alvin J. Siteman Cancer Center
Present

University of Chicago
2002–2004
Internal Medicine
1999–2002
UNIV OF IBADAN COLL OF MED, IBADAN, OYO STATE, NIGERIA
1995–1999

Research

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Nature Genetics · 2013 · 458 citations
Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Nature Genetics · 2013 · 347 citations
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
Clinical Cancer Research · 2017 · 308 citations

CM
Cynthia Ma
26 papers
Katherine Weilbaecher
12 papers
Katherine Clifton
11 papers
ME
Matthew Ellis
11 papers
RS
Rama Suresh
11 papers
Rebecca Aft
11 papers
William Gillanders
10 papers
Ashley Frith
9 papers
RB
Ron Bose
9 papers
Ian Hagemann
8 papers
Julie Margenthaler
8 papers
LP
Lindsay Peterson
8 papers

Clinical trials

Overcoming Racial Disparities in Screening Mammography
Principal investigator · Not yet recruiting
Washington University School of Medicine
2026–2028
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
Principal investigator · Active not recruiting
Rna Diagnostics Inc.
2018–2031
Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer
Principal investigator · Terminated · Phase 2
Washington University School of Medicine
2017–2020
Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer
Principal investigator · Withdrawn · Phase 2
Washington University School of Medicine
2014–2015